| Nicholas B Argento, MDL | |
|
14201 Laurel Park Dr, Suite 214, Laurel, MD 20707-5203 | |
| (301) 953-2080 | |
| (301) 953-3543 |
| Full Name | Nicholas B Argento |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 39 Years |
| Location | 14201 Laurel Park Dr, Laurel, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093781155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | D34018 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maryland Endocrine, P.a. | 4082659529 | 10 |
News Archive
A study of pharmaceutical companies' marketing to physicians shows that doctors are most influenced by brand preference and marketing that addresses the problems of drugs with many side effects, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS).
A new study published in the January 11, 2010 issue of the journal Alzheimer's and Dementia, finds that symptoms of cognitive decline can be experienced some 20 years before an Alzheimer's diagnosis.
A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The University of Texas M. D. Anderson Cancer Center report in the early online edition of the journal Immunity.
Lockheed Martin has been awarded $170 million in new Health & Human Services (HHS) information technology contracts, all geared toward improving efficiency in our nation's health systems.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
› Verified 8 days ago
| Entity Name | Maryland Endocrine, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316913486 PECOS PAC ID: 4082659529 Enrollment ID: O20050624000242 |
News Archive
A study of pharmaceutical companies' marketing to physicians shows that doctors are most influenced by brand preference and marketing that addresses the problems of drugs with many side effects, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS).
A new study published in the January 11, 2010 issue of the journal Alzheimer's and Dementia, finds that symptoms of cognitive decline can be experienced some 20 years before an Alzheimer's diagnosis.
A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The University of Texas M. D. Anderson Cancer Center report in the early online edition of the journal Immunity.
Lockheed Martin has been awarded $170 million in new Health & Human Services (HHS) information technology contracts, all geared toward improving efficiency in our nation's health systems.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas B Argento, MDL 14201 Laurel Park Dr, Suite 214, Laurel, MD 20707-5203 Ph: (301) 953-2080 | Nicholas B Argento, MDL 14201 Laurel Park Dr, Suite 214, Laurel, MD 20707-5203 Ph: (301) 953-2080 |
News Archive
A study of pharmaceutical companies' marketing to physicians shows that doctors are most influenced by brand preference and marketing that addresses the problems of drugs with many side effects, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS).
A new study published in the January 11, 2010 issue of the journal Alzheimer's and Dementia, finds that symptoms of cognitive decline can be experienced some 20 years before an Alzheimer's diagnosis.
A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The University of Texas M. D. Anderson Cancer Center report in the early online edition of the journal Immunity.
Lockheed Martin has been awarded $170 million in new Health & Human Services (HHS) information technology contracts, all geared toward improving efficiency in our nation's health systems.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
› Verified 8 days ago
Dr. Aruna Paspula, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 13900 Baltimore Ave, Laurel, MD 20707 Phone: 301-725-5652 Fax: 301-483-5723 | |
Darryl A Hill, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 13635 Baltimore Ave, Laurel, MD 20707 Phone: 301-497-0601 Fax: 301-497-0402 | |
Jenny Yamhah Moy, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 13952 Baltimore Ave, Laurel, MD 20707 Phone: 301-490-1990 Fax: 301-490-8750 | |
Jerry A Hunter, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3357b Corridor Marketplace, Laurel, MD 20724 Phone: 301-497-5489 | |
Heidi A. Karon, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 14201 Laurel Park Dr, Suite 214, Laurel, MD 20707 Phone: 301-953-2080 Fax: 301-953-3543 | |
Dr. Padmaja S Udapi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 7350 Van Dusen Rd, Suite# 380, Laurel, MD 20707 Phone: 301-776-6514 Fax: 301-776-6592 |